Author Details

Yatskov, K. V.

Issue Section Title File
Vol 17, No 2 (2022) TREATMENT OF HEMATOLOGICAL MALIGNANCIES IN PATIENTS WITH COVID-19: PRO AND CONTRA Chemotherapy of hematological malignancies in patients with COVID-19 PDF
(Rus)
Vol 18, No 4 (2023): Supplement Articles Basic therapeutic approaches to the management of hematology/oncology patients with new coronavirus infection (COVID-19) PDF
(Rus)
Vol 18, No 4 (2023): Supplement Articles Treatment features of adult patients with acute myeloid leukemia during the COVID-19 pandemic PDF
(Rus)
Vol 18, No 4 (2023): Supplement Articles Coronavirus infection after blood stem cell transplantation PDF
(Rus)
Vol 18, No 4 (2023): Supplement Articles Clinical features and treatment strategy for patients with multiple myeloma during the COVID-19 pandemic PDF
(Rus)
Vol 18, No 4 (2023): Supplement Articles Chronic lymphocytic leukemia in combination with COVID-19: clinical features and unfavorable prognosis factors PDF
(Rus)
Vol 18, No 4 (2023): Supplement Articles COVID-19 in patients with acute leukemia: 3 years' experience of pandemic PDF
(Rus)
Vol 18, No 4 (2023): Supplement Articles Treatment experience of coronavirus infection associated with SARS-CoV-2 in patients with acute myeloid leukemia in the older age group PDF
(Rus)
Vol 18, No 4 (2023): Supplement Articles Prognostic model and risk factors for hospital mortality in patients with diffuse large B-cell lymphoma associated with coronavirus infection: a single-center cohort study PDF
(Rus)
Vol 19, No 2 (2024) RARE AND COMPLEX CLINICAL SITUATIONS: DIAGNOSIS AND TREATMENT CHOICE Sinonasal diffuse large B-cell lymphoma: own clinical observation and literature review PDF
(Rus)
Vol 19, No 3 (2024) NEW DIRECTIONS, DIAGNOSTIC OPPORTUNITIES, AND TREATMENT ADVANCES Treatment efficiency in patients with acute myeloid leukemia from 2019 to 2023 according to the Moscow Cancer Registry PDF
(Rus)
Vol 19, No 3 (2024) TREATMENT OF HEMATOLOGICAL MALIGNANCIES IN PATIENTS WITH COVID-19 COVID-19 in patients with acute lymphoblastic leukemia PDF
(Rus)
Vol 19, No 4 (2024) HEMATOLOGIC MALIGNANCIES: TREATMENT Treatment of elderly patients with acute myeloid leukemia: personal experience PDF
(Rus)
Vol 19, No 4 (2024) NEW DIRECTIONS, DIAGNOSTIC OPPORTUNITIES, AND TREATMENT ADVANCES Nivolumab-containing therapy in patients with newly diagnosed classical Hodgkin lymphoma: own clinical observations and literature review PDF
(Rus)
Vol 19, No 4 (2024) NEW DIRECTIONS, DIAGNOSTIC OPPORTUNITIES, AND TREATMENT ADVANCES Personalized genotype-directed antitumor therapy for newly diagnosed diffuse large B-cell lymphoma: efficacy and toxicity of the R-CHOP-X protocol in a single-center, non-randomized, prospective clinical trial (first results) PDF
(Rus)
Vol 20, No 3 (2025) HEMATOLOGIC MALIGNANCIES: TREATMENT Molecular phenotype of diffuse large B-cell lymphoma as a basis for a personalized treatment approach of elderly patients PDF
(Rus)
Vol 20, No 3 (2025) HEMATOLOGIC MALIGNANCIES: TREATMENT Experience with acalabrutinib as a component of molecularly adapted antitumor therapy according to the R-CHOP-X protocol in patients with newly diagnosed diffuse large B-cell lymphoma PDF
(Rus)
Vol 20, No 4 (2025) HEMATOLOGIC MALIGNANCIES: TREATMENT Multiple myeloma: a retrospective analysis of clinical outcomes based on the patient registry of the Moscow City Clinical Hospital No. 52 (2022–2025) PDF
(Rus)

The website of the journal Oncohematology contains materials intended exclusively for healthcare professionals.

By closing this message, you confirm* that you are a licensed healthcare professional or a student of a medical educational institution.

This one-time confirmation is valid for the next 30 days.